News
.png)
Dr. Paul Billings Joins Lindus Health's Scientific Advisory Board
Lindus Health has announced the appointment of Dr. Paul Billings to its Scientific Advisory Board, strengthening its expertise in diagnostic and genomic medicine. A recognized leader in diagnostics with decades of experience across industry and clinical research, Dr. Billings will help guide Lindus Health’s strategy for designing and executing high-quality diagnostic clinical trials, supporting faster, more reliable paths from diagnostic innovation to patient impact.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
%2520(1).jpeg)
Why I joined Lindus Health? Van Zyl Engelbrecht
The mission to accelerate clinical trial. The focus on making clinical research more patient-centric. The ability to support innovative health companies bring their product to market at a lower cost.
Clinical trial launches to develop Diagnostic Tampon for at-home HPV and STI testing
We're excited to announce that we've launched a clinical study with Daye, a UK-based gynaecological health startup, to develop a Diagnostic Tampon for at-home HPV and STI testing.
Lindus Health and Oto launch remote trial to combat tinnitus
We're excited to announce that we've launched a fully remote clinical study with Oto, a UK-based digital health startup, to combat tinnitus.
Announcing our $18m Series A led by investors Creandum and with participation from Peter Thiel
The funding comes from Spotify-backer Creandum, with participation from PayPal co-founder Peter Thiel and returning investors firstminute, Seedcamp, Hambro Perks, Amino Collective, Page One Ventures and Calm/Storm. Additional investment has been provided by angel investors including Nadav Rosenberg, Kaysan Nikkhah, Trevor Martin, Soraya Darabi, Andrej Steinberg, Tom Krüger and Mithi Thaya.
Why I joined Lindus Health - Anthony Brogno, Director of Clinical Operations
To break the mold of the CRO status quo. To leverage social medial and technology to support research operations. The Lindus Health culture. Hear more from Anthony Brogno, Director of Clinical Operations, on why he joined Lindus Health.
.png)
The FDA's DCT Draft Guidance: What's Missing?
The FDA recently released draft guidance on DCTs. Whilst this is a significant step towards providing a clear framework for implementing DCTs, some parts could be expanded on for the industry to take full advantage of their potential. We reflected on our learnings from delivering DCTs to highlight three key areas we think can benefit from additional detail: participant engagement, recruitment and retention, and the handling of investigational products.
Best practices for advancing clinical research in the community
Hear from Chris Williams, a friend of Lindus Health and founder of Tiggo Care - a community care business supporting vulnerable adults in London - about best practices for conducting clinical research in the community.
Improving the reliability of clinical trial data, fuelled by Innovate UK's Smart Grant
Effective clinical data management represents a fundamental part of any clinical trial, impacting safety, data integrity and the reliability of results upon which regulatory approvals are made. Through the use of AI detection models and deep learning techniques, we overcome these limitations with a product capable of real-time data capture, safety monitoring and advanced data analytics - fuelled by Innovate UK's Smart Grant.
Discussing DTx payor reimbursement and adoption with Mike Pace (PalmHealthCo and ex-Pear Tx)
Mike Pace stops by our virtual fireplace to share tips on how to achieve payor reimbursement for DTx products and encourage adoption among clinicians in the most attractive international markets.